Soluble CD14 from urine copurifies with a potent inducer of cytokines
- 1 August 1994
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 24 (8), 1779-1784
- https://doi.org/10.1002/eji.1830240809
Abstract
Here we report that soluble CD14 isolated from the urine of nephrotic patients (uCD14) contains a potent cytokine inducing activity. CD14 derived from urine appeared to consist of two major polypeptides of about 54 and 48 kDa. In uCD14 isolated from three different nephrotic patients the cytokine-inducing activity appeared to co-migrate with the 48-kDa polypeptide which upon sequencing had the same N-terminal sequence as native CD14. Treatment of human monocytes and the human astrocytoma cell line U373 with uCD14 resulted in a strong secretion of tumor necrosis factor (TNF) and interleukin-6, respectively. The cytokine-inducing activity of the uCD14 preparations was unaffected by the absence of serum. This is in contrast to the activation of human monocytes and U373 cells by lipopolysaccharide (LPS) which is highly dependent on the presence of serum. The cytokine-inducing activity was not affected by LPS-binding protein (LBP) or polyclonal rabbit antibodies against LBP The TNF-inducing activity of uCD14 was also heat labile in contrast to the cytokine-inducing activity of LPS, which was relatively heat resistant. The results suggest that CD14 may exist in at least two forms of which one is involved in cytokine induction.Keywords
This publication has 30 references indexed in Scilit:
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD 14Molecular Immunology, 1989
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin ResistanceScience, 1986
- Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigenEuropean Journal of Immunology, 1986
- Self-regulation of procoagulant events on the endothelial cell surface.The Journal of Experimental Medicine, 1985
- Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages.The Journal of Experimental Medicine, 1983
- Structural Analysis of Differentiation Antigens Mol and Mo2 On Human MonocytesHybridoma, 1982